![](/img/cover-not-exists.png)
PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis
Mestre, L, Redondo, M, Carrillo-Salinas, F J, Morales-García, J A, Alonso-Gil, S, Pérez-Castillo, A, Gil, C, Martínez, A, Guaza, CVolume:
172
Language:
english
Journal:
British Journal of Pharmacology
DOI:
10.1111/bph.13192
Date:
September, 2015
File:
PDF, 1.60 MB
english, 2015